OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune System Dysregulation in the Progression of Multiple Sclerosis: Molecular Insights and Therapeutic Implications
Zuber Khan, Sidharth Mehan, Ghanshyam Das Gupta, et al.
Neuroscience (2024) Vol. 548, pp. 9-26
Closed Access | Times Cited: 13

Showing 13 citing articles:

Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges
Kamran Sheikhi, Sara Ghaderi, Hassan Firouzi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access | Times Cited: 1

Does Clostridium Perfringens Epsilon Toxin Mimic an Auto-Antigen Involved in Multiple Sclerosis?
Marie‐Lise Gougeon, Valérie Seffer, Cezarela Hoxha, et al.
Toxins (2025) Vol. 17, Iss. 1, pp. 27-27
Open Access

Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders
Azhagu Madhavan Sivalingam
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access

Navigating the Complexities of Neuronal Signaling and Targets in Neurological Disorders: From Pathology to Therapeutics
Divya Choudhary, Muhammad Imran Khan, Zuber Khan, et al.
European Journal of Pharmacology (2025), pp. 177417-177417
Closed Access

The Multifaceted Role of CS1 (SLAMF7) in Immunoregulation: Implications for Cancer Therapy and Autoimmune Disorders
Farag M. A. Altalbawy, Zarrina Babamuradova, Lalji Baldaniya, et al.
Experimental Cell Research (2025), pp. 114516-114516
Closed Access

Molecular mechanisms of GDNF/GFRA1/RET and PI3K/AKT/ERK signaling interplay in neuroprotection: Therapeutic strategies for treating neurological disorders
Manzar Khan, Divya Choudhary, Sidharth Mehan, et al.
Neuropeptides (2025) Vol. 111, pp. 102516-102516
Closed Access

Current challenges in secondary progressive multiple sclerosis: diagnosis, activity detection and treatment
Luís Brieva, Carmen Calles, Lamberto Landete, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Exosomes in the Diagnosis of Neuropsychiatric Diseases: A Review
Song Wu, Xin-miao Shang, Meng Guo, et al.
Biology (2024) Vol. 13, Iss. 6, pp. 387-387
Open Access | Times Cited: 3

GV‐971 attenuates the progression of neuromyelitis optica in murine models and reverses alterations in gut microbiota and associated peripheral abnormalities
Xinying Yang, Zhongheng Zhangyi, Aisong Yu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 1

Can International Classification of Functioning, Disability and Health (ICF) Be Used for Prediction of Work Capacity and Employment Status in Multiple Sclerosis?
Daiva Valadkevičienė, Dalius Jatužis, Irena Žukauskaitė, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4195-4195
Open Access

Page 1

Scroll to top